Niche CRO Next Breath specializes in in vitro services for pharmaceutical, biotech and medical device clients focusing on inhalation and nasal delivery, presenting a targeted opportunity to upsell contract research and analytical testing services to companies developing pulmonary products.

Regulatory Support With capabilities spanning pre-clinical formulation development to regulatory submissions testing, there is a sales angle around comprehensive E&L (extractables and leachables) and cGMP analytical services that align with clients seeking regulatory readiness for inhalation and injectable systems.

Partner Ecosystem Historical collaborations (e.g., with Gateway Analytical and Circassia) and a position as a liaison between drug developers and device inventors suggest opportunities to co-sell or introduce Next Breath to manufacturers and device developers needing specialized packaging, delivery and compatibility testing.

Growth Signals Recent news around expanding cGMP analytical services and injectable delivery system support signals capacity for larger projects and longer engagements, enabling sales discussions around scale-up testing programs and phased outsourcing.

Industry Position As a recognized center for in vitro pharmaceutical equivalence and a division with strong focus on inhalation nasal products, Next Breath offers a credible partner for firms seeking proven expertise in pulmonary product development and regulatory-ready bench services, opening doors with biotech and pharma clients pursuing inhalation platforms.